相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Paul Feuerstadt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
The Future of Uncertainty Factors With In Vitro Studies Using Human Cells
Michael Dourson et al.
TOXICOLOGICAL SCIENCES (2022)
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
Satoru Yonekura et al.
CANCER DISCOVERY (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A. Lee et al.
NATURE MEDICINE (2022)
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazli Dizman et al.
NATURE MEDICINE (2022)
Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according toFusobacterium nucleatumstatus
Ji Ae Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
The intratumoral microbiome: Characterization methods and functional impact
Clement J. F. Heymann et al.
CANCER LETTERS (2021)
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam et al.
CELL (2021)
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Golnaz Morad et al.
CELL (2021)
Gut microbiota influence tumor development and Alter interactions with the human immune system
Yanshan Ge et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Defining HPV-specific B cell responses in patients with head and neck cancer
Andreas Wieland et al.
NATURE (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
Abigail E. Overacre-Delgoffe et al.
IMMUNITY (2021)
Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells
Charles Maisonneuve et al.
CELL REPORTS (2021)
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
Gladys Ferrere et al.
JCI INSIGHT (2021)
Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites
Claudia Grajeda-Iglesias et al.
Aging-US (2021)
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone et al.
NATURE MEDICINE (2021)
The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk
Dong D. Wang et al.
NATURE MEDICINE (2021)
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
Nicolo Pernigoni et al.
SCIENCE (2021)
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N. Spencer et al.
SCIENCE (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota
Francesco Durazzi et al.
SCIENTIFIC REPORTS (2021)
Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition
Laura C. D. Pomatto-Watson et al.
NATURE COMMUNICATIONS (2021)
Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?
Alain Menzel et al.
ANTIOXIDANTS (2021)
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment
Uqba Khan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2021)
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae
Anne-Gaelle Goubet et al.
CELL DEATH AND DIFFERENTIATION (2021)
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He et al.
CELL METABOLISM (2021)
Haematological Malignancies in Older People 1 A comprehensive approach to therapy of haematological malignancies in older patients
Raul Cordoba et al.
LANCET HAEMATOLOGY (2021)
Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
Jinzhu Mao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Applying artificial intelligence in the microbiome for gastrointestinal diseases: A review
Tao Zeng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Identification of bacteria-derived HLA-bound peptides in melanoma
Shelly Kalaora et al.
NATURE (2021)
Effect of tectonic processes on biosphere-geosphere feedbacks across a convergent margin
Katherine M. Fullerton et al.
NATURE GEOSCIENCE (2021)
The microbiome and human cancer
Gregory D. Sepich-Poore et al.
SCIENCE (2021)
Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect
Erez N. Baruch et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice
Hyo Shin Yoon et al.
NATURE MICROBIOLOGY (2021)
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews et al.
NATURE MEDICINE (2021)
Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
Matthew E. Griffin et al.
SCIENCE (2021)
The Cancer Microbiome: Recent Highlights and Knowledge Gaps
Reece J. Knippel et al.
CANCER DISCOVERY (2021)
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa et al.
CANCER DISCOVERY (2021)
NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells
Yuetong Wang et al.
CELL REPORTS (2021)
Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response
Benjamin Ruf et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
Hao Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
Ye Zhao et al.
FRONTIERS IN IMMUNOLOGY (2021)
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota
Stephen J. Blake et al.
CELL REPORTS MEDICINE (2021)
Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)
J. Nicholas Bodor et al.
CANCER (2020)
Toll-like Receptor-6 Signaling Prevents Inflammation and Impacts Composition of the Microbiota During Inflammation-Induced Colorectal Cancer
Jee-Hyun Kim et al.
CANCER PREVENTION RESEARCH (2020)
Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
Shipra Das et al.
CANCER RESEARCH (2020)
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
Anthony R. Cillo et al.
IMMUNITY (2020)
Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
Amelie Lopes et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer
Ching-Wei Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer
Aparna Mitra et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Impact of antibiotic exposure on the efficacy of immune checkpoint blockade in MSI-H metastatic CRC.
Victoria Serpas et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
Yaoyao Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Complete, closed bacterial genomes from microbiomes using nanopore sequencing
Eli L. Moss et al.
NATURE BIOTECHNOLOGY (2020)
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab A Phase 2 Clinical Trial
Ciara M. Kelly et al.
JAMA ONCOLOGY (2020)
Acetate promotes SNAI1 expression by ACSS2-mediated histone acetylation under glucose limitation in renal cell carcinoma cell
Lv Yao et al.
BIOSCIENCE REPORTS (2020)
Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy
Pablo Nenclares et al.
EUROPEAN JOURNAL OF CANCER (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
Kurt Selle et al.
MBIO (2020)
Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein
Hui-wen Xiao et al.
MICROBIOME (2020)
Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Gregory D. Poore et al.
NATURE (2020)
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
Maria Paula Roberti et al.
NATURE MEDICINE (2020)
Beyond Just Bacteria: Functional Biomes in the Gut Ecosystem Including Virome, Mycobiome, Archaeome and Helminths
Ravichandra Vemuri et al.
MICROORGANISMS (2020)
Bacteriophage-mediated manipulation of the gut microbiome - promises and presents limitations
Torben Solbeck Rasmussen et al.
FEMS MICROBIOLOGY REVIEWS (2020)
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
Tania Rossi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity
Catherine A. Bessell et al.
JCI INSIGHT (2020)
The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer
Adrienne Halley et al.
ANTICANCER RESEARCH (2020)
Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis
Poshen B. Chen et al.
NATURE BIOTECHNOLOGY (2020)
Gut microbiome, big data and machine learning to promote precision medicine for cancer
Giovanni Cammarota et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors
Nicholas J. Salgia et al.
EUROPEAN UROLOGY (2020)
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus
Jyh-Ming Liou et al.
GUT (2020)
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buque et al.
NATURE COMMUNICATIONS (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
Zhi Peng et al.
CANCER IMMUNOLOGY RESEARCH (2020)
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer
Taiki Hakozaki et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
Hechen Huang et al.
GENOME MEDICINE (2020)
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurelie Fluckiger et al.
SCIENCE (2020)
Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome
Maurice Barrett et al.
TRENDS IN CANCER (2020)
Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics
F. Huemer et al.
ANNALS OF ONCOLOGY (2019)
Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders
Elena Biagi et al.
BMC MEDICAL GENOMICS (2019)
Modulating the microbiome to improve therapeutic response in cancer
Jennifer L. McQuade et al.
LANCET ONCOLOGY (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
The microbiome, cancer, and cancer therapy
Beth A. Helmink et al.
NATURE MEDICINE (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations
Raphael Eisenhofer et al.
TRENDS IN MICROBIOLOGY (2019)
The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
Delphine L. Laute-Caly et al.
SCIENTIFIC REPORTS (2019)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip
Sasan Jalili-Firoozinezhad et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Yizel Becerril-Alarcon et al.
CARDIOVASCULAR THERAPEUTICS (2019)
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Mary Ellen Sanders et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences
Himel Mallick et al.
NATURE COMMUNICATIONS (2019)
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with updates hepatocellular carcinoma
Yi Zheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
Sally Temraz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
TLR1/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage
Yuting Deng et al.
MOLECULAR IMMUNOLOGY (2019)
The future of faecal transplants
Edward M. Giles et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Microbial metabolites control the thymic development of mucosal-associated invariant T cells
Francois Legoux et al.
SCIENCE (2019)
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
Sarah Levesque et al.
ONCOIMMUNOLOGY (2019)
Studying the gut virome in the metagenomic era: challenges and perspectives
Sanzhima Garmaeva et al.
BMC BIOLOGY (2019)
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
Berk Aykut et al.
NATURE (2019)
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
M. Oliva et al.
ANNALS OF ONCOLOGY (2019)
Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?
Andrew B. Nixon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Microbiota and cancer immunotherapy: in search of microbial signals
Raad Z. Gharaibeh et al.
GUT (2019)
Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin
Zhen He et al.
GUT (2019)
Role of the microbiome in human development
Maria Gloria Dominguez-Bello et al.
GUT (2019)
Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis
Huali Yin et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu et al.
NATURE MEDICINE (2019)
Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
Rachel Howard et al.
SCIENTIFIC REPORTS (2019)
Dynamic host immune response in virus-associated cancers
Song Cao et al.
COMMUNICATIONS BIOLOGY (2019)
Harnessing the Microbiome for Pancreatic Cancer Immunotherapy
Gerardo A. Vitiello et al.
TRENDS IN CANCER (2019)
Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study
Zongxin Ling et al.
FRONTIERS IN IMMUNOLOGY (2019)
Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade
Feng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome
Austin Yan et al.
ACS INFECTIOUS DISEASES (2018)
Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
Liam Chung et al.
CELL HOST & MICROBE (2018)
Next-generation sequencing technologies and their application to the study and control of bacterial infections
J. Besser et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The fecal metabolome as a functional readout of the gut microbiome
Jonas Zierer et al.
NATURE GENETICS (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Christine M. Dejea et al.
SCIENCE (2018)
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma et al.
SCIENCE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
Julie R. Brahmer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism
Ting Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Carbotoxicity-Noxious Effects of Carbohydrates
Guido Kroemer et al.
CELL (2018)
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Alexandria P. Cogdill et al.
TRENDS IN IMMUNOLOGY (2018)
Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data
Nicole M. Davis et al.
MICROBIOME (2018)
Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside
Triantafyllos Stylianopoulos et al.
TRENDS IN CANCER (2018)
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide et al.
CLINICAL CANCER RESEARCH (2018)
Challenges in Personalized Nutrition and Health
Meghna Verma et al.
FRONTIERS IN NUTRITION (2018)
A human pilot trial of ingestible electronic capsules capable of sensing different gases in the gut
Kourosh Kalantar-Zadeh et al.
NATURE ELECTRONICS (2018)
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong-Yi Dong et al.
CLINICAL CANCER RESEARCH (2017)
Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of DNAemia
T. Gosiewski et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Helicobacter pylori Infection Modulates the Expression of miRNAs Associated With DNA Mismatch Repair Pathway
Juliana C. Santos et al.
MOLECULAR CARCINOGENESIS (2017)
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
Hubert Plovier et al.
NATURE MEDICINE (2017)
Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3 Activity
Thi Thinh Nguyen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Lisa Derosa et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Influence of the microbiota on host physiology - moving beyond the gut
Kim E. Barrett et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Evidence for early life in Earth's oldest hydrothermal vent precipitates
Matthew S. Dodd et al.
NATURE (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
The role of the microbiome in human health and disease: an introduction for clinicians
Vincent B. Young
BMJ-BRITISH MEDICAL JOURNAL (2017)
The role of the microbiome in human health and disease: an introduction for clinicians
Vincent B. Young
BMJ-BRITISH MEDICAL JOURNAL (2017)
ADXS11-001 Lm-LLO Immunotherapy, Mitomycin, 5-fluorouracil (5-FU) and Intensity modulated radiation therapy (IMRT) for Anal Cancer.
Howard Safran et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
EBV based cancer prevention and therapy in nasopharyngeal carcinoma
Ya Cao
NPJ PRECISION ONCOLOGY (2017)
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
TaChung Yu et al.
CELL (2017)
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation
Daniela Weber et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Faecal microbiota transplantation protects against radiation-induced toxicity
Ming Cui et al.
EMBO MOLECULAR MEDICINE (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Spontaneous regression of tumour and the role of microbial infection - possibilities for cancer treatment
Petra Kucerova et al.
ANTI-CANCER DRUGS (2016)
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Federico Pietrocola et al.
CANCER CELL (2016)
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
Mariette I. E. van Poelgeest et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
HPV E7 antigen-expressing Listeria-based immunotherapy (ADXS11-001) prior to robotic surgery for HPV-positive oropharyngeal cancer enhances HPV-specific T cell immunity
Rosemarie Krupar et al.
CANCER RESEARCH (2016)
Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer
Elena Cherkasova et al.
CANCER RESEARCH (2016)
Development of of stable isotope dilution assays for the quantitation of intra- and extracellular folate patterns of Bifidobacterium adolescentis
Markus Kopp et al.
JOURNAL OF CHROMATOGRAPHY A (2016)
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
David N. O'Dwyer et al.
JOURNAL OF IMMUNOLOGY (2016)
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Louis Fehrenbacher et al.
LANCET (2016)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
The Human Intestinal Microbiome in Health and Disease
Susan V. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen et al.
CANCER DISCOVERY (2016)
Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples
Angela Glassing et al.
GUT PATHOGENS (2016)
Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
Heikki Huhta et al.
ONCOTARGET (2016)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis et al.
CELL REPORTS (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota
Natali Pflug et al.
ONCOIMMUNOLOGY (2016)
Human endogenous retroviruses and cancer
Maria Gonzalez-Cao et al.
CANCER BIOLOGY & MEDICINE (2016)
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Robert R. Jenq et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT
E. Biagi et al.
BONE MARROW TRANSPLANTATION (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Innate sensing of microbial products promotes wound-induced skin cancer
Esther Hoste et al.
NATURE COMMUNICATIONS (2015)
Ranking the impact of human health disorders on gut metabolism: Systemic lupus erythematosus and obesity as study cases
David Rojo et al.
SCIENTIFIC REPORTS (2015)
The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease
Robert P. Dickson et al.
PLOS PATHOGENS (2015)
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Kosuke Mima et al.
JAMA ONCOLOGY (2015)
Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study
Aiping Wang et al.
PLOS ONE (2015)
Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease
Ernst Holler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Helicobacter pylori-induced gastric inflammation and gastric cancer
Fei Wang et al.
CANCER LETTERS (2014)
Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells
Antoaneta Belcheva et al.
CELL (2014)
Molecular Pathways: Gene-Environment Interactions Regulating Dietary Fiber Induction of Proliferation and Apoptosis via Butyrate for Cancer Prevention
Scott J. Bultman
CLINICAL CANCER RESEARCH (2014)
Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro
Karen P. Scott et al.
FEMS MICROBIOLOGY ECOLOGY (2014)
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
Nagendra Singh et al.
IMMUNITY (2014)
Associations of the Fecal Microbiome With Urinary Estrogens and Estrogen Metabolites in Postmenopausal Women
Barbara J. Fuhrman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Towards Predictive Models of the Human Gut Microbiome
Vanni Bucci et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Common Contaminants in Next-Generation Sequencing That Hinder Discovery of Low-Abundance Microbes
Martin Laurence et al.
PLOS ONE (2014)
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
Nicholas J. Roberts et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Clinical update on cancer: molecular oncology of head and neck cancer
Y. Suh et al.
CELL DEATH & DISEASE (2014)
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Mara Roxana Rubinstein et al.
CELL HOST & MICROBE (2013)
Helicobacter pylori Causes Epigenetic Dysregulation of FOXD3 to Promote Gastric Carcinogenesis
Alfred S. L. Cheng et al.
GASTROENTEROLOGY (2013)
Genomes of Microbes Inhabiting the Body Offer Clues to Human Health and Disease
M. J. Friedrich
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Shin Yoshimoto et al.
NATURE (2013)
Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System
Benjamin Kraus et al.
PLOS ONE (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
Structure and function of the human skin microbiome
Nina N. Schommer et al.
TRENDS IN MICROBIOLOGY (2013)
An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins
Oliver David Kenneth Maddocks et al.
MBIO (2013)
Role of the gut microbiota in immunity and inflammatory disease
Nobuhiko Kamada et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Vaginal Microbiome: Rethinking Health and Disease
Bing Ma et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 66 (2012)
Human Microbiome in Health and Disease
Kathryn J. Pflughoeft et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Gut microbiota-derived propionate reduces cancer cell proliferation in the liver
L. B. Bindels et al.
BRITISH JOURNAL OF CANCER (2012)
Bacterial Inactivation of the Anticancer Drug Doxorubicin
Erin L. Westman et al.
CHEMISTRY & BIOLOGY (2012)
Commensal Bacteria Calibrate the Activation Threshold of Innate Antiviral Immunity
Michael C. Abt et al.
IMMUNITY (2012)
Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study
Roberto Flores et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Microbiota-Targeted Therapies: An Ecological Perspective
Katherine P. Lemon et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
In vitro bioaccessibility and gut biotransformation of polyphenols present in the water-insoluble cocoa fraction
Vincenzo Fogliano et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Peripheral education of the immune system by colonic commensal microbiota
Stephanie K. Lathrop et al.
NATURE (2011)
Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages
Rasika N. Jinadasa et al.
MICROBIOLOGY-SGM (2011)
Prospects for systems biology and modeling of the gut microbiome
Fredrik H. Karlsson et al.
TRENDS IN BIOTECHNOLOGY (2011)
Bacteriophages and cancer
Paulina Budynek et al.
ARCHIVES OF MICROBIOLOGY (2010)
Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells
Min Kyung Baek et al.
CANCER LETTERS (2010)
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells
Gabriel Cuevas-Ramos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Microbes in Gastrointestinal Health and Disease
Andrew S. Neish
GASTROENTEROLOGY (2009)
The Innate Immune Receptor Nod1 Protects the Intestine from Inflammation-induced Tumorigenesis
Grace Y. Chen et al.
CANCER RESEARCH (2008)
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis
Djahida Bouskra et al.
NATURE (2008)
Deoxycholic acid promotes the growth of colonic aberrant crypt foci
Christopher Flynn et al.
MOLECULAR CARCINOGENESIS (2007)
Adaptation of solitary intestinal lymphoid tissue in response to microbiota and chemokine receptor CCR7 signaling
Oliver Pabst et al.
JOURNAL OF IMMUNOLOGY (2006)
Nod1-dependent control of tumor growth
JD Correia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: The effect and problems
MH Chang et al.
CLINICAL CANCER RESEARCH (2005)
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
SK Mazmanian et al.
CELL (2005)
Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells
JJ Kim et al.
GASTROENTEROLOGY (2002)
The origin of atmospheric oxygen on Earth: The innovation of oxygenic photosynthesis
GC Dismukes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)